Dr. Curran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
180 Harvester Dr
Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064Fax+1 773-702-8702
Summary
- Dr. James Curran is a rheumatologist in Chicago, IL and is affiliated with University of Chicago Medical Center. He received his medical degree from University of Illinois College of Medicine and has been in practice 40 years. He specializes in myositis, rheumatoid arthritis & related, and vasculitis and is experienced in polymyositis, inflammatory myopathies, and intersitial lung disease: synthetase syndromes.
Education & Training
- University of ChicagoFellowship, Rheumatology, 1980 - 1982
- National Capital ConsortiumResidency, Internal Medicine, 1978 - 1980
- National Capital ConsortiumInternship, Internal Medicine, 1976 - 1977
- University of Illinois College of MedicineClass of 1976
Certifications & Licensure
- IL State Medical License 1980 - 2026
- MD State Medical License 1984 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Master American College of Rheumatology, 2015
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Publications & Presentations
PubMed
- 131 citationsThe Diagnosis and Treatment of Antisynthetase Syndrome.Leah J. Witt, James J. Curran, Mary E. Strek
Clinical Pulmonary Medicine. 2016-09-01 - 34 citationsBenefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease☆Leah J. Witt, Carley Demchuk, James J. Curran, Mary E. Strek
Pulmonary Pharmacology & Therapeutics. 2016-02-01 - 22 citationsCritical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis.Linda Hushaw, Ray Sawaqed, Ghaleb J. Sweis, Jori Reigle, Anjali Gopal
Therapeutics and Clinical Risk Management. 2010-04-15
Press Mentions
- Emory Center for AIDS Research Awarded $11.25 Million NIH RenewalAugust 9th, 2022
- Epidemiologist: Georgia COVID Risk High Despite Case DeclineSeptember 14th, 2021
- State's Top Public Health Official Tears up, Thanks Workers for Continuing Despite Being 'Ridiculed'September 14th, 2021
- Join now to see all
Professional Memberships
- Master
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: